Baeg Song In, Lee Kyungho, Jeon Junseok, Jang Hye Ryoun
Division of Nephrology, Department of Internal Medicine, Myongji Hospital, Hanyang University Medical Center, Goyang, Republic of Korea.
Division of Nephrology, Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Republic of Korea.
Electrolyte Blood Press. 2022 Dec;20(2):64-75. doi: 10.5049/EBP.2022.20.2.64. Epub 2022 Dec 30.
Despite the lack of proven superiority in mortality compared to intermittent hemodialysis, continuous renal replacement therapy (CRRT) is the preferred renal replacement therapy modality for critically ill patients with acute kidney injury (AKI) due to better hemodynamic stability and steady correction of electrolytes disturbances and volume overload. Multiple and complex electrolyte disorders in patients with AKI can be managed effectively with CRRT because controlled and predictable correction is feasible. Thus, CRRT has an advantage with safety over conventional hemodialysis, especially in patients with both renal dysfunction and electrolyte disorder that require a sophisticated treatment with avoidance of rapid correction. On the contrary, CRRT can potentially lead to paradoxical disturbance of electrolytes such as hypokalemia or hypophosphatemia, especially in patients under high dose or prolonged duration of CRRT treatment. These electrolytes related complications can be prevented with close monitoring followed by the appropriate use of CRRT fluids. Although there is a lack of solid evidence and standardized guideline for CRRT prescriptions, optimal management of various electrolyte disturbances can be achieved with individualized and tailored dialysate and replacement fluid prescriptions. Several commercially available CRRT solutions with varying compositions provide flexibility to manage electrolyte disorders and maintain the stability of electrolyte. In this review, we discuss various prescription methods to manage common electrolyte imbalances as well as preventative strategies to maintain electrolyte homeostasis during CRRT providing detailed protocols used in our center. This review may contribute to future research that can lead to the development of clinical practice guidelines.
尽管与间歇性血液透析相比,连续肾脏替代治疗(CRRT)在降低死亡率方面缺乏已证实的优势,但由于其具有更好的血流动力学稳定性,能稳定纠正电解质紊乱和容量超负荷,因此是急性肾损伤(AKI)危重症患者首选的肾脏替代治疗方式。AKI患者的多种复杂电解质紊乱可通过CRRT有效处理,因为进行可控且可预测的纠正具有可行性。因此,与传统血液透析相比,CRRT在安全性方面具有优势,尤其是对于那些同时存在肾功能不全和电解质紊乱且需要精细治疗以避免快速纠正的患者。相反,CRRT可能会导致诸如低钾血症或低磷血症等矛盾性电解质紊乱,特别是在接受高剂量或长时间CRRT治疗的患者中。通过密切监测并合理使用CRRT置换液,可以预防这些与电解质相关的并发症。尽管目前缺乏关于CRRT处方的确凿证据和标准化指南,但通过个体化和定制的透析液及置换液处方,可以实现对各种电解质紊乱的最佳管理。几种成分不同的市售CRRT溶液为处理电解质紊乱和维持电解质稳定性提供了灵活性。在本综述中,我们讨论了处理常见电解质失衡的各种处方方法以及在CRRT期间维持电解质稳态的预防策略,并提供了我们中心使用的详细方案。本综述可能有助于未来开展研究,从而推动临床实践指南的制定。